Cancer News and Stories
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Filtering by:
LeukemiaFDA Approves 2 Drugs for Acute Myeloid Leukemia (AML)
Published on: November 27, 2018
The US Food and Drug Administration (FDA) has approved 2 new drugs, Daurismo (glasdegib) and Venclexta (venetoclax), to treat people newly diagnosed with acute myeloid leukemia (AML) who are not candidates for intensive chemotherapy.
Leukemia Survivor Opens Up About His Cancer
Published on: October 16, 2018
Leukemia survivor Lloyd Sutton says the only time he really felt shaky was the night he spent in the emergency room in May 2015.
FDA Approves Lumoxiti (Moxetumomab Pasudotox) for Hairy Cell Leukemia
Published on: September 14, 2018
The US Food and Drug Administration (FDA) has approved Lumoxiti (moxetumomab pasudotox-tdfk) for adults with hairy cell leukemia (HCL) that did not get better with at least 2 different previous treatments or got better but then came back.
FDA Approves Tibsovo (Ivosidenib) for Acute Myeloid Leukemia (AML)
Published on: July 24, 2018
The US Food and Drug Administration (FDA) has approved the targeted therapy drug Tibsovo (ivosidenib) to treat some adults with a certain type of acute myeloid leukemia (AML).
FDA Approves Venclexta (Venetoclax) for a Type of Chronic Lymphocytic Leukemia
Published on: April 12, 2016
The US Food and Drug Administration (FDA) has approved a new targeted therapy for a certain type of chronic lymphocytic leukemia (CLL).